ProfileGDS5822 / ILMN_1254263
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 7% 7% 29% 2% 23% 12% 48% 29% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 18.97
GSM1276600PDAC Late Ablation Control 210.77
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 113.429
GSM1276603PDAC Late Ablation 23.32
GSM1276604PDAC Late Ablation 313.223
GSM1303940PDAC Late Ablation_anti-CTLA4 110.312
GSM1303941PDAC Late Ablation_anti-CTLA4 223.948
GSM1303942PDAC Late Ablation_anti-CTLA4 314.429